Company / Gross Profit per Share
Bristol Myers Squibb Gross Profit per Share History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$18.78
FY2020
5-year range
-
FY2016-FY2020
Trend
+92.8%
vs FY2019
Sector context
#3 of 29
Health Care
What the data says
Among 29 Health Care companies, Bristol Myers Squibb is in the top 10% for gross profit per share. Improved from $8.74 to $18.78 over the past 2 years.
Based on SEC 10-K filings.
18.78 in FY2020 with a 3-year CAGR of +29.0%. Ranks 3rd among 29 companies in Health Care.
Improved from $8.74 to $18.78 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +29.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 29This company $18.78 Sector average $8.11
▼
+131.7% above sector average
Key checks
Key Insights
- In FY2020, gross profit per share increased 92.8% year-over-year.
- Ranks #3 out of 29 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $18.78 | +92.8% |
| FY2019 | $9.74 | +11.5% |
| FY2018 | $8.74 | -0.1% |
| FY2017 | $8.74 | +15.4% |
| FY2016 | $7.58 | +5.4% |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026